Suppr超能文献

新冠疫苗接种在印度的强大保护作用——第二波疫情期间的调查结果

Robust Protective Effect of COVID-19 Vaccination in India-Results of Survey in the Midst of Pandemic's Second Wave.

作者信息

Parikh Purvish M, Maheshwari Udip, Krishna V M, Gupta S, Patil T, Mandhaniya S, Mehta P, Somashekhar S P, Parekh B, Singh R

机构信息

Mumbai Oncocare Centers, Mumbai, Maharashtra, India.

Department of Medical Oncology, Mumbai Oncocare Centers, Mumbai, Maharashtra, India.

出版信息

South Asian J Cancer. 2021 Jan;10(1):28-31. doi: 10.1055/s-0041-1733320. Epub 2021 Aug 21.

Abstract

Our objective was to document the incidence of COVID-19 in vaccinated health care professionals and related personnel.  We conducted an online survey to ascertain the incidence of COVID-19 symptoms, reverse transcriptase polymerase chain reaction (RT-PCR) positivity, effect on normal activity, need for anti-COVID-19 medication, hospitalization, and death among individuals who had completed both doses of COVID vaccination at least 2 weeks earlier.  A total of 351 unique valid responses were received. Among the 340 people who had been vaccinated in India, 5% (17/340) had COVID-19 symptoms, 4.7% (16) became COVID-19 RT-PCR positive, 12 (3.5%) had sickness preventing normal daily activity, 2.65% (9) required anti-COVID-19 medication, and 1.18% (4) required hospitalization. Among family members living with the survey responders, the corresponding incidence was even lower. There was one death in this group.  Being health care professionals, the responders would be at higher risk of daily exposure to COVID-19. Even in this high risk group, the vaccine efficacy is good. Vulture journalists should stop spreading fake news and misinformation that makes people hesitate taking the vaccine or be afflicted analysis paralysis. Every person who chooses to remain unvaccinated increases the risk for our entire community. We also need to follow universal precautions (wearing mask, physical distancing, handwashing) diligently without letting down our guard.

摘要

我们的目标是记录接种疫苗的医护人员及相关人员中新冠病毒病(COVID-19)的发病率。

我们开展了一项在线调查,以确定至少在两周前已完成两剂新冠疫苗接种的人员中出现COVID-19症状、逆转录酶聚合酶链反应(RT-PCR)呈阳性、对正常活动的影响、是否需要抗COVID-19药物治疗、住院情况及死亡情况的发生率。

共收到351份有效回复。在340名在印度接种过疫苗的人员中,5%(17/340)出现COVID-19症状,4.7%(16人)RT-PCR检测呈COVID-19阳性,12人(3.5%)因病无法进行正常日常活动,2.65%(9人)需要抗COVID-19药物治疗,1.18%(4人)需要住院治疗。在与调查对象共同生活的家庭成员中,相应的发病率更低。该组有1人死亡。

作为医护人员,调查对象日常接触COVID-19的风险更高。即便在这个高风险群体中,疫苗效果依然良好。无良记者应停止传播虚假新闻和错误信息,这些信息会让人们对接种疫苗犹豫不决或陷入分析瘫痪状态。每一个选择不接种疫苗的人都会增加我们整个社区的风险。我们还需要严格遵守普遍预防措施(佩戴口罩、保持社交距离、洗手),不能有丝毫松懈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c887/8380146/66458889f6d1/10-1055-s-0041-1733320_50435_01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验